FDA Moves to Reevaluate Several Peptides American Med Spa Association The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Report: FDA Set to Unban RFK Jr.'s Favorite Peptides Clinical and Legal Considerations in Pharmaceutical Compounding JCAD The Journal of Clinical and Aesthetic Dermatology FDA Removes Key Peptides from Category 2: What This Means for You